A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
Clinical trial NCT01310816 · COMPLETED
Trial details
- NCT number
- NCT01310816
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-11-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.